SELLAS Life Sciences (SLS) Non-Current Debt (2013 - 2018)

SELLAS Life Sciences (SLS) has 5 years of Non-Current Debt data on file, last reported at $1.2 million in Q1 2018.

• On a quarterly basis, Non-Current Debt changed N/A year-over-year to $1.2 million in Q1 2018; TTM through Mar 2018 was $1.2 million, a N/A change from a year earlier, with the FY2017 full-year figure at $2.6 million, changed N/A from the prior year.
• Non-Current Debt for Q1 2018 stood at $1.2 million, down from $2.6 million in the prior quarter.
• Over the last five years, Non-Current Debt for SLS reached as high as $6.9 million in Q1 2014 and fell as low as $1.2 million in Q1 2018.
• Historically, Non-Current Debt has averaged $3.8 million across 4 years, with a median of $3.5 million in 2015.
• Across the five-year window, Non-Current Debt sank 36.16% in 2014 and sank 70.06% in 2015, its largest moves.
• Year by year, Non-Current Debt stood at $4.5 million in 2014, then tumbled by 66.03% to $1.5 million in 2015, then surged by 71.1% to $2.6 million in 2017, then sank by 55.96% to $1.2 million in 2018.
• Per Business Quant data, the three most recent Non-Current Debt figures were $1.2 million in Q1 2018, $2.6 million in Q4 2017, and $1.5 million in Q3 2015.